StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
16
This year
3
Publishing Date
2024 - 03 - 21
1
2024 - 01 - 09
1
2024 - 01 - 02
1
2023 - 12 - 12
1
2023 - 12 - 06
1
2023 - 12 - 04
1
2023 - 11 - 17
2
2023 - 11 - 15
1
2023 - 11 - 02
1
2023 - 09 - 12
1
2023 - 05 - 04
1
2023 - 01 - 20
1
2023 - 01 - 05
1
2022 - 08 - 31
2
Sector
Communications
2
Electronic technology
4
Health technology
6
Tags
Ad685
1
Application
2
Asia
1
Automotive
1
Autonomous
3
Back
2
Biotech-bay
1
Commercial
3
Company
6
Conference
1
Designation
2
Disorders
1
Drug
2
Family
2
Fast track designation
2
Fda
2
Granted
2
Growth
1
Market
2
N/a
14
One
1
Patent
3
Reach
1
Regulatory
1
Report
1
Skin
1
Software
1
Sp-103
4
State
2
Study
1
Treatment
4
Trucks
1
Ztlido
10
Entities
Ambarella, inc.
4
Astrazeneca plc
1
Johnson & johnson
1
Orange
2
Scilex holding company
8
Sorrento therapeutics, inc.
4
Taro pharmaceutical industries ltd.
1
Symbols
AMBA
4
AZN
1
AZNCF
1
FNCTF
2
JNJ
1
SCLX
8
SRNE
4
TARO
1
Exchanges
Nasdaq
15
Nyse
2
Crawled Date
2024 - 03 - 21
1
2024 - 01 - 09
1
2024 - 01 - 02
1
2023 - 12 - 12
1
2023 - 12 - 06
1
2023 - 12 - 04
1
2023 - 11 - 17
2
2023 - 11 - 15
1
2023 - 11 - 02
1
2023 - 09 - 12
1
2023 - 05 - 04
1
2023 - 01 - 20
1
2023 - 01 - 05
1
2022 - 08 - 31
2
Crawled Time
04:00
1
08:00
1
10:00
3
13:00
2
13:30
1
14:00
3
14:30
1
17:00
2
18:00
1
23:00
1
Source
www.biospace.com
2
www.globenewswire.com
12
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
LIDOCAINE
save search
Lidocaine Hydrochloride Market Forecasted to Reach USD 1.56 Billion by 2034 with Robust Growth in Asia Pacific Region
Published:
2024-03-21
(Crawled : 18:00)
- prnewswire.com
AZNCF
|
$135.305
1.1K
|
Health Technology
|
3.29%
|
O:
0.01%
H:
0.0%
C:
0.0%
JNJ
|
$143.92
-0.37%
3.2M
|
Health Technology
|
-7.15%
|
O:
-0.03%
H:
0.0%
C:
0.0%
AZN
|
$68.55
0.42%
2.2M
|
Health Technology
|
3.86%
|
O:
1.34%
H:
0.27%
C:
-0.63%
reach
asia
growth
market
Ambarella Expands Autonomous Driving AI Domain Controller Family With Two New Members; Provides Broadest Software-Compatible AI Performance Range
Published:
2024-01-09
(Crawled : 10:00)
- globenewswire.com
AMBA
|
$44.2
-0.65%
170K
|
Electronic Technology
|
-22.5%
|
O:
-1.13%
H:
3.53%
C:
1.97%
autonomous
family
Kodiak Robotics Selects Ambarella AI Domain Controller SoC For Next-Generation Autonomous Trucks
Published:
2024-01-02
(Crawled : 10:00)
- globenewswire.com
AMBA
|
$44.2
-0.65%
170K
|
Electronic Technology
|
-27.41%
|
O:
-1.52%
H:
1.87%
C:
-0.36%
autonomous
trucks
Ambarella Unveils Full Software Stack for Autonomous and Semi-Autonomous Driving, Optimized for its CV3-AD Central AI Domain Controller Family
Published:
2023-12-12
(Crawled : 10:00)
- globenewswire.com
AMBA
|
$44.2
-0.65%
170K
|
Electronic Technology
|
-27.59%
|
O:
0.1%
H:
0.65%
C:
-1.03%
autonomous
software
family
Scilex Holding Company announces that ZTlido® (lidocaine topical system) will be added as a preferred agent to the Medicaid Preferred Drug List (PDL) in two new states: one Midwestern and one Southern State
Published:
2023-12-06
(Crawled : 14:30)
- globenewswire.com
SCLX
|
$1.175
1.29%
130K
|
|
-1.69%
|
O:
0.85%
H:
1.68%
C:
-4.2%
ztlido
drug
company
state
one
Scilex Holding Company announces the addition of ZTlido® (lidocaine topical system) as a preferred agent to the Medicaid Preferred Drug List (PDL) of the State of Tennessee
Published:
2023-12-04
(Crawled : 14:00)
- globenewswire.com
SCLX
|
$1.175
1.29%
130K
|
|
-14.07%
|
O:
2.22%
H:
5.43%
C:
-5.8%
ztlido
drug
company
state
Scilex Holding Company Announces Issuance of a Second New Patent in the U.S. for Its Lead Commercial Product ZTlido® (lidocaine topical system)
Published:
2023-11-17
(Crawled : 17:00)
- biospace.com/
SCLX
|
$1.175
1.29%
130K
|
|
8.41%
|
O:
5.61%
H:
0.0%
C:
-5.31%
ztlido
patent
company
commercial
Scilex Holding Company Announces Issuance of a Second New Patent in the U.S. for Its Lead Commercial Product ZTlido® (lidocaine topical system) for a Method of Relieving Pain Through the Application of a Non-Aqueous Lidocaine-Containing Patch
Published:
2023-11-17
(Crawled : 14:00)
- globenewswire.com
SCLX
|
$1.175
1.29%
130K
|
|
8.41%
|
O:
5.61%
H:
0.0%
C:
-5.31%
ztlido
patent
company
commercial
application
Scilex Holding Company Announces Issuance of New Patent in the U.S. for Its Lead Commercial Product ZTlido® (lidocaine topical system) for a Method of Relieving Pain Through the Application of a Lidocaine-Containing Patch
Published:
2023-11-15
(Crawled : 14:00)
- globenewswire.com
SCLX
|
$1.175
1.29%
130K
|
|
-5.69%
|
O:
3.25%
H:
9.45%
C:
-0.79%
ztlido
patent
company
commercial
application
Scilex Holding Company Announces New Data From Deeper Skin Penetration Studies to Support SP-103 (lidocaine topical system) 5.4%, a Triple Strength Formulation of ZTlido®, in Treatment of Musculoskeletal Pain Disorders
Published:
2023-11-02
(Crawled : 13:00)
- globenewswire.com
SCLX
|
$1.175
1.29%
130K
|
|
-35.91%
|
O:
2.76%
H:
7.53%
C:
-0.54%
sp-103
ztlido
company
disorders
treatment
skin
Scilex Holding Company Presented Oral and Poster Presentations on ZTlido (lidocaine topical system) at the 2023 Annual PAINWeek Conference Held in Las Vegas, NV
Published:
2023-09-12
(Crawled : 13:30)
- globenewswire.com
SCLX
|
$1.175
1.29%
130K
|
|
-51.87%
|
O:
2.49%
H:
2.83%
C:
-1.21%
SRNE
|
$0.0275
53K
|
Health Technology
|
-86.9%
|
O:
-3.62%
H:
7.95%
C:
-8.1%
conference
ztlido
Scilex Holding Company Announces Complete Enrollment of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain
Published:
2023-05-04
(Crawled : 13:00)
- globenewswire.com
SCLX
|
$1.175
1.29%
130K
|
|
-78.91%
|
O:
0.0%
H:
4.91%
C:
-4.36%
SRNE
|
$0.0275
53K
|
Health Technology
|
-88.59%
|
O:
-0.46%
H:
2.92%
C:
-0.5%
sp-103
ztlido
back
treatment
study
Lidocaine Ointment Market Report 2022: With Key Trends, Drivers, Players and Forecasts to 2030
Published:
2023-01-20
(Crawled : 23:00)
- prnewswire.com
TARO
|
$42.245
0.46%
3.8K
|
Health Technology
|
Email alert
Add to watchlist
report
market
Ambarella Expands CV3 Family of Automotive AI Domain Controllers With New CV3-AD685
Published:
2023-01-05
(Crawled : 17:00)
- globenewswire.com
AMBA
|
$44.2
-0.65%
170K
|
Electronic Technology
|
-43.87%
|
O:
-0.95%
H:
2.92%
C:
-0.84%
ad685
automotive
Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute LBP
Published:
2022-08-31
(Crawled : 08:00)
- biospace.com/
SRNE
|
$0.0275
53K
|
Health Technology
|
-98.58%
|
O:
5.15%
H:
2.94%
C:
0.49%
sp-103
ztlido
treatment
fda
designation
granted
fast track designation
Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain (LBP)
Published:
2022-08-31
(Crawled : 04:00)
- globenewswire.com
SRNE
|
$0.0275
53K
|
Health Technology
|
-98.58%
|
O:
5.15%
H:
2.94%
C:
0.49%
sp-103
ztlido
treatment
fda
designation
back
granted
fast track designation
Gainers vs Losers
64%
36%
Top 10 Gainers
INVO
|
$2.78
265.79%
200M
|
Health Technology
RYDE
|
$4.66
70.7%
410K
|
n/a
EDBL
|
$7.4
62.64%
12M
|
GRTX
|
$0.237
39.41%
13M
|
Health Technology
VNDA
|
$5.28
30.37%
21M
|
Health Technology
VIRX
|
$0.912
27.59%
170K
|
Manufacturing
WISA
4
|
$7.72
26.56%
51M
|
Electronic Technology
TCON
|
$2.135
24.85%
440K
|
Health Technology
AGFY
|
$0.37
24.2%
28M
|
BCAN
|
$1.085
23.73%
7.4M
|
Construction
Your saved searches
Save your searches and get alerts when important news are released.